These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26714853)

  • 1. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
    Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
    BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin.
    Kumar K; Gordon C; Toescu V; Buckley CD; Horne R; Nightingale PG; Raza K
    Rheumatology (Oxford); 2008 May; 47(5):690-7. PubMed ID: 18375972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'It's like taking poison to kill poison but I have to get better': a qualitative study of beliefs about medicines in Rheumatoid arthritis and Systemic lupus erythematosus patients of South Asian origin.
    Kumar K; Gordon C; Barry R; Shaw K; Horne R; Raza K
    Lupus; 2011 Jul; 20(8):837-44. PubMed ID: 21511761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
    McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
    J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
    Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
    RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China.
    Wei L; Champman S; Li X; Li X; Li S; Chen R; Bo N; Chater A; Horne R
    BMJ Open; 2017 Oct; 7(10):e017293. PubMed ID: 28982826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
    Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
    BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Cea-Calvo L; Raya E; Marras C; Salman-Monte TC; Ortiz A; Salvador G; Monteagudo I; Carmona L; Fernandez S; Arteaga MJ; Calvo-Allén J
    Rheumatol Int; 2018 Sep; 38(9):1735-1740. PubMed ID: 29959469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
    Kawahito Y; Takakubo Y; Morinobu A; Matsubara N; Nagy O; Sugiyama E
    PLoS One; 2021; 16(11):e0259389. PubMed ID: 34780502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaming for Adherence to Medication using Ehealth in Rheumatoid arthritis (GAMER) study: a randomised controlled trial.
    Pouls BPH; Bekker CL; Gundogan F; Hebing RC; van Onzenoort HA; van de Ven LI; Vonkeman HE; Tieben R; Vriezekolk JE; van Dulmen S; Van den Bemt B
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36410776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial.
    Zwikker HE; van den Ende CH; van Lankveld WG; den Broeder AA; van den Hoogen FH; van de Mosselaar B; van Dulmen S; van den Bemt BJ
    Patient Educ Couns; 2014 Mar; 94(3):356-61. PubMed ID: 24388126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.
    van den Bemt BJ; van den Hoogen FH; Benraad B; Hekster YA; van Riel PL; van Lankveld W
    J Rheumatol; 2009 Oct; 36(10):2164-70. PubMed ID: 19723906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence.
    van Heuckelum M; Linn AJ; Vandeberg L; Hebing RCF; van Dijk L; Vervloet M; Flendrie M; Nurmohamed MT; van Dulmen S; van den Bemt BJF; van den Ende CHM
    PLoS One; 2019; 14(8):e0221290. PubMed ID: 31469852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial mediation of illness perception and beliefs about medicines in the relationship between patient satisfaction and medication adherence: An evaluation of self-regulatory model in rheumatoid arthritis and ankylosing spondylitis patients.
    Temeloglu Sen E; Sertel Berk HO; Rezvani A
    J Health Psychol; 2024 Jul; 29(8):836-847. PubMed ID: 38014636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of using musculoskeletal ultrasound imaging and other influencing factors on medication adherence in patients with rheumatoid arthritis: a qualitative study.
    Kumar K; Raza K; Gill P; Greenfield S
    Patient Prefer Adherence; 2016; 10():1091-100. PubMed ID: 27366054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of elderly- and young-onset rheumatoid arthritis in an Asian cohort.
    Tan TC; Gao X; Thong BY; Leong KP; Lian TY; Law WG; Kong KO; Howe HS; Chng HH; Koh ET;
    Int J Rheum Dis; 2017 Jun; 20(6):737-745. PubMed ID: 27135312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. South Asians living in the UK and adherence to coronary heart disease medication: a mixed- method study.
    Jalal Z; Antoniou S; Taylor D; Paudyal V; Finlay K; Smith F
    Int J Clin Pharm; 2019 Feb; 41(1):122-130. PubMed ID: 30564971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' Attitudes and Experiences of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis.
    Kelly A; Tymms K; Tunnicliffe DJ; Sumpton D; Perera C; Fallon K; Craig JC; Abhayaratna W; Tong A
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):525-532. PubMed ID: 28732151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial origin and its effect on disease expression and HLA-DRB1 types in patients with rheumatoid arthritis: a matched cross-sectional study.
    Griffiths B; Situnayake RD; Clark B; Tennant A; Salmon M; Emery P
    Rheumatology (Oxford); 2000 Aug; 39(8):857-64. PubMed ID: 10952739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.